{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:44:34Z","timestamp":1785843874669,"version":"3.56.0"},"reference-count":48,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T00:00:00Z","timestamp":1704931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Identification of the optimal treatment strategy is challenging in elderly with localized non-small cell lung cancer (NSCLC). Concurrent chemotherapy with low-dose cisplatin represents an option for elderly. Outcomes (1) in elderly (\u226570 years, n = 158) vs. younger patients (n = 188) and (2), independently of age, in definitive radiochemotherapy, with low-dose cisplatin (n = 125) vs. cisplatin\/vinorelbine (n = 76) were studied. Elderly included more males, had a lower Karnofsky index, more comorbidities, and lower stages. Low-dose cisplatin patients (vs. cisplatin\/vinorelbine) had higher age, more comorbidities, and lower stages. We observed reduced dermatitis and dysphagia and increased anemia and thrombocytopenia in elderly vs. younger patients, without increased \u2265grade 3 toxicities. Low-dose cisplatin was less toxic than cisplatin\/vinorelbine. Survival outcomes were lower in elderly vs. younger and comparable between low-dose cisplatin and cisplatin\/vinorelbine. In elderly, gender, Karnofsky index, stage, and multimodal treatment (including additional surgery\/systemic therapy) were identified as prognostic factors. In conclusion, we found evidence for an acceptable toxicity profile and the need for improvement of outcomes in elderly with localized NSCLC. Multimodal strategies (including additional surgery\/systemic treatment) showed favorable outcomes and should be reasonably considered in elderly who are deemed fit enough. Low-dose cisplatin should be discussed on an individual basis due to favorable toxicity and outcomes.<\/jats:p>","DOI":"10.3390\/cancers16020327","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T12:56:33Z","timestamp":1704977793000},"page":"327","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Outcomes of Multimodal Treatment in Elderly Patients with Localized Non-Small Lung Cancer from a Radiation Oncology Point of View: Special Focus on Low-Dose Cisplatin"],"prefix":"10.3390","volume":"16","author":[{"given":"Niklas Josua","family":"Alt","sequence":"first","affiliation":[{"name":"Department of Radiotherapy and Radiation Oncology, University Medical Center G\u00f6ttingen, Robert-Koch-Str. 40, 37075 G\u00f6ttingen, Germany"},{"name":"G\u00f6ttingen Comprehensive Cancer Center (G-CCC), University Medical Center G\u00f6ttingen, Von-Bar-Str. 2\/4, 37075 G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Muster","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Radiation Oncology, University Medical Center G\u00f6ttingen, Robert-Koch-Str. 40, 37075 G\u00f6ttingen, Germany"},{"name":"G\u00f6ttingen Comprehensive Cancer Center (G-CCC), University Medical Center G\u00f6ttingen, Von-Bar-Str. 2\/4, 37075 G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Alexander","family":"Ziegler","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Radiation Oncology, University Medical Center G\u00f6ttingen, Robert-Koch-Str. 40, 37075 G\u00f6ttingen, Germany"},{"name":"G\u00f6ttingen Comprehensive Cancer Center (G-CCC), University Medical Center G\u00f6ttingen, Von-Bar-Str. 2\/4, 37075 G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Bendrich","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Radiation Oncology, University Medical Center G\u00f6ttingen, Robert-Koch-Str. 40, 37075 G\u00f6ttingen, Germany"},{"name":"G\u00f6ttingen Comprehensive Cancer Center (G-CCC), University Medical Center G\u00f6ttingen, Von-Bar-Str. 2\/4, 37075 G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Donath","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Radiation Oncology, University Medical Center G\u00f6ttingen, Robert-Koch-Str. 40, 37075 G\u00f6ttingen, Germany"},{"name":"G\u00f6ttingen Comprehensive Cancer Center (G-CCC), University Medical Center G\u00f6ttingen, Von-Bar-Str. 2\/4, 37075 G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Hille","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Radiation Oncology, University Medical Center G\u00f6ttingen, Robert-Koch-Str. 40, 37075 G\u00f6ttingen, Germany"},{"name":"G\u00f6ttingen Comprehensive Cancer Center (G-CCC), University Medical Center G\u00f6ttingen, Von-Bar-Str. 2\/4, 37075 G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahalia Zoe","family":"Anczykowski","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Radiation Oncology, University Medical Center G\u00f6ttingen, Robert-Koch-Str. 40, 37075 G\u00f6ttingen, Germany"},{"name":"G\u00f6ttingen Comprehensive Cancer Center (G-CCC), University Medical Center G\u00f6ttingen, Von-Bar-Str. 2\/4, 37075 G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla Marie","family":"Zwerenz","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Radiation Oncology, University Medical Center G\u00f6ttingen, Robert-Koch-Str. 40, 37075 G\u00f6ttingen, Germany"},{"name":"G\u00f6ttingen Comprehensive Cancer Center (G-CCC), University Medical Center G\u00f6ttingen, Von-Bar-Str. 2\/4, 37075 G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friederike","family":"Braulke","sequence":"additional","affiliation":[{"name":"G\u00f6ttingen Comprehensive Cancer Center (G-CCC), University Medical Center G\u00f6ttingen, Von-Bar-Str. 2\/4, 37075 G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"von Hammerstein-Equord","sequence":"additional","affiliation":[{"name":"G\u00f6ttingen Comprehensive Cancer Center (G-CCC), University Medical Center G\u00f6ttingen, Von-Bar-Str. 2\/4, 37075 G\u00f6ttingen, Germany"},{"name":"Department of Cardio-Thoracic and Vascular Surgery, University Medical Center G\u00f6ttingen, Robert-Koch-Str. 40, 37075 G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2579-0171","authenticated-orcid":false,"given":"Tobias Raphael","family":"Overbeck","sequence":"additional","affiliation":[{"name":"G\u00f6ttingen Comprehensive Cancer Center (G-CCC), University Medical Center G\u00f6ttingen, Von-Bar-Str. 2\/4, 37075 G\u00f6ttingen, Germany"},{"name":"Department of Hematology and Medical Oncology, University Medical Center G\u00f6ttingen, Robert-Koch-Str. 40, 37075 G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4436-5493","authenticated-orcid":false,"given":"Hannes","family":"Treiber","sequence":"additional","affiliation":[{"name":"G\u00f6ttingen Comprehensive Cancer Center (G-CCC), University Medical Center G\u00f6ttingen, Von-Bar-Str. 2\/4, 37075 G\u00f6ttingen, Germany"},{"name":"Department of Hematology and Medical Oncology, University Medical Center G\u00f6ttingen, Robert-Koch-Str. 40, 37075 G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Guhlich","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Radiation Oncology, University Medical Center G\u00f6ttingen, Robert-Koch-Str. 40, 37075 G\u00f6ttingen, Germany"},{"name":"G\u00f6ttingen Comprehensive Cancer Center (G-CCC), University Medical Center G\u00f6ttingen, Von-Bar-Str. 2\/4, 37075 G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"El Shafie","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Radiation Oncology, University Medical Center G\u00f6ttingen, Robert-Koch-Str. 40, 37075 G\u00f6ttingen, Germany"},{"name":"G\u00f6ttingen Comprehensive Cancer Center (G-CCC), University Medical Center G\u00f6ttingen, Von-Bar-Str. 2\/4, 37075 G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Rieken","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Radiation Oncology, University Medical Center G\u00f6ttingen, Robert-Koch-Str. 40, 37075 G\u00f6ttingen, Germany"},{"name":"G\u00f6ttingen Comprehensive Cancer Center (G-CCC), University Medical Center G\u00f6ttingen, Von-Bar-Str. 2\/4, 37075 G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Leu","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Radiation Oncology, University Medical Center G\u00f6ttingen, Robert-Koch-Str. 40, 37075 G\u00f6ttingen, Germany"},{"name":"G\u00f6ttingen Comprehensive Cancer Center (G-CCC), University Medical Center G\u00f6ttingen, Von-Bar-Str. 2\/4, 37075 G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5378-4246","authenticated-orcid":false,"given":"Leif Hendrik","family":"Dr\u00f6ge","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Radiation Oncology, University Medical Center G\u00f6ttingen, Robert-Koch-Str. 40, 37075 G\u00f6ttingen, Germany"},{"name":"G\u00f6ttingen Comprehensive Cancer Center (G-CCC), University Medical Center G\u00f6ttingen, Von-Bar-Str. 2\/4, 37075 G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,1,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.annonc.2023.01.010","article-title":"European cancer mortality predictions for the year 2023 with focus on lung cancer","volume":"34","author":"Malvezzi","year":"2023","journal-title":"Ann. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jtho.2022.03.010","article-title":"Lung Cancer in Germany","volume":"17","author":"Frost","year":"2022","journal-title":"J. Thorac. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"S908","DOI":"10.21037\/jtd.2016.05.20","article-title":"Lung cancer in elderly patients","volume":"8","author":"Venuta","year":"2016","journal-title":"J. Thorac. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"109853","DOI":"10.3389\/fepid.2023.1109853","article-title":"Patterns of care and survival for lung cancer: Results of the European population-based high-resolution study","volume":"3","author":"Sant","year":"2023","journal-title":"Front. Epidemiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2147\/ciia.2006.1.3.253","article-title":"Effect of aging on respiratory system physiology and immunology","volume":"1","author":"Sharma","year":"2006","journal-title":"Clin. Interv. Aging"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"S422","DOI":"10.1513\/AnnalsATS.201602-095AW","article-title":"Aging of the Immune System. Mechanisms and Therapeutic Targets","volume":"13","author":"Weyand","year":"2016","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2217\/ahe.09.74","article-title":"Community-acquired pneumonia in elderly patients","volume":"5","author":"Stupka","year":"2009","journal-title":"Aging health"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1758835920923430","article-title":"Cisplatin-induced renal toxicity in elderly people","volume":"12","author":"Duan","year":"2020","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jgo.2021.02.003","article-title":"Are clinical trial eligibility criteria representative of older patients with lung cancer? A population-based data linkage study","volume":"12","author":"Tang","year":"2021","journal-title":"J. Geriatr. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1007\/s12094-023-03286-3","article-title":"Expert consensus to optimize the management of older adult patients with advanced EGFR-mutated non-small cell lung cancer","volume":"25","author":"Nadal","year":"2023","journal-title":"Clin. Transl. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0959-8049(00)00169-6","article-title":"Geriatric oncology: Challenges for the new century","volume":"36","author":"Balducci","year":"2000","journal-title":"Eur. J. Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"103378","DOI":"10.1016\/j.critrevonc.2021.103378","article-title":"Treatment strategies for locally advanced non-small cell lung cancer in elderly patients: Translating scientific evidence into clinical practice","volume":"163","author":"Bonanno","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1556-0864(15)31598-7","article-title":"Management of Unresected Stage III Non-small Cell Lung Cancer: A Systematic Review","volume":"1","author":"Okawara","year":"2006","journal-title":"J. Thorac. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13014-019-1239-7","article-title":"Comparative efficacy and safety for different chemotherapy regimens used concurrently with thoracic radiation for locally advanced non-small cell lung cancer: A systematic review and network meta-analysis","volume":"14","author":"Liu","year":"2019","journal-title":"Radiat. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00066-016-0941-8","article-title":"GILT\u2014A randomised phase III study of oral vinorelbine and cisplatin with concomitant radiotherapy followed by either consolidation therapy with oral vinorelbine and cisplatin or best supportive care alone in stage III non-small cell lung cancer","volume":"192","author":"Flentje","year":"2016","journal-title":"Strahlenther. Onkol."},{"key":"ref_16","unstructured":"(2023, November 07). S3-Leitlinie: Pr\u00e4vention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms. Available online: https:\/\/www.leitlinienprogramm-onkologie.de\/fileadmin\/user_upload\/Downloads\/Leitlinien\/Lungenkarzinom\/Version_2\/LL_Lungenkarzinom_Langversion_2.2.pdf."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJM199202203260805","article-title":"Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer","volume":"326","author":"Dalesio","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cllc.2013.03.002","article-title":"Toxicity of concurrent radiochemotherapy for locally advanced non--small-cell lung cancer: A systematic review of the literature","volume":"14","author":"Koning","year":"2013","journal-title":"Clin. Lung Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa1809697","article-title":"Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC","volume":"379","author":"Antonia","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_20","unstructured":"National Comprehensive Cancer Network (2023, November 07). Non-Small Cell Lung Cancer. Available online: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/nscl.pdf."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2018.02.023","article-title":"ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer","volume":"127","author":"Nestle","year":"2018","journal-title":"Radiother. Oncol."},{"key":"ref_22","unstructured":"National Cancer Institute (2023, November 08). Common Terminology Criteria for Adverse Events (CTCAE), Available online: https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm."},{"key":"ref_23","unstructured":"American Joint Committee on Cancer (2010). AJCC Cancer Staging Manual, Springer. [7th ed.]."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Wittekind, C., Asamura, H., and Sobin, L.H. (2014). TNM Atlas: Illustrated Guide to the TNM Classification of Malignant Tumours, Wiley-Blackwell. [6th ed.].","DOI":"10.1002\/9781118695647"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","article-title":"The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer","volume":"11","author":"Goldstraw","year":"2016","journal-title":"J. Thorac. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1055\/s-0043-119186","article-title":"Staging des Lungenkarzinoms nach der revidierten TNM-Klassifikation","volume":"17","author":"Niehoff","year":"2017","journal-title":"Radiol. up2date"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Gross, A., Ziepert, M., and Scholz, M. (2012). KMWin\u2014A convenient tool for graphical presentation of results from Kaplan-Meier survival time analysis. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0038960"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1200\/JCO.2016.71.4758","article-title":"Pooled Analysis of Individual Patient Data on Concurrent Chemoradiotherapy for Stage III Non-Small-Cell Lung Cancer in Elderly Patients Compared With Younger Patients Who Participated in US National Cancer Institute Cooperative Group Studies","volume":"35","author":"Stinchcombe","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"ed119","DOI":"10.3332\/ecancer.2021.ed119","article-title":"How aging of the global population is changing oncology","volume":"15","author":"Gu","year":"2021","journal-title":"Ecancermedicalscience"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Zaborowska-Szmit, M., Olszyna-Serementa, M., Kowalski, D.M., Szmit, S., and Krzakowski, M. (2021). Elderly Patients with Locally Advanced and Unresectable Non-Small-Cell Lung Cancer May Benefit from Sequential Chemoradiotherapy. Cancers, 13.","DOI":"10.3390\/cancers13184534"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1634\/theoncologist.2014-0247","article-title":"Geriatric Assessment-Identified Deficits in Older Cancer Patients With Normal Performance Status","volume":"20","author":"Jolly","year":"2015","journal-title":"Oncologist"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/bjc.2017.455","article-title":"Geriatric assessment may help decision-making in elderly patients with inoperable, locally advanced non-small-cell lung cancer","volume":"118","author":"Antonio","year":"2018","journal-title":"Br. J. Cancer"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jgo.2010.12.002","article-title":"Screening older cancer patients for a Comprehensive Geriatric Assessment: A comparison of three instruments","volume":"2","author":"Owusu","year":"2011","journal-title":"J. Geriatr. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1200\/JCO.2011.39.5269","article-title":"Impact of age and comorbidity on non-small-cell lung cancer treatment in older veterans","volume":"30","author":"Wang","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_35","first-page":"20210058","article-title":"Prospective multicentre analysis of the therapeutic approach and prognostic factors determining overall survival in elderly patients with non-small-cell lung carcinoma treated with curative intent","volume":"4","author":"Cacicedo","year":"2022","journal-title":"BJR Open"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.radonc.2016.07.025","article-title":"Stage III Non-Small Cell Lung Cancer in the elderly: Patient characteristics predictive for tolerance and survival of chemoradiation in daily clinical practice","volume":"121","author":"Driessen","year":"2016","journal-title":"Radiother. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3389\/fphar.2020.00975","article-title":"Comparison of Myelotoxicity and Nephrotoxicity Between Daily Low-Dose Cisplatin With Concurrent Radiation and Cyclic High-Dose Cisplatin in Non-Small Cell Lung Cancer Patients","volume":"11","author":"Zazuli","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Weiling, M.J., Losensky, W., W\u00e4chter, K., Schilling, T., Frank, F., Haas, M., Fietkau, R., Distel, L.V., and Weiss, S. (2018). Older Patients Are Less Affected by Radiochemotherapeutic Treatment than Younger. Biomed. Res. Int., 2018.","DOI":"10.1155\/2018\/5471054"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1053\/j.seminhematol.2008.06.001","article-title":"Anemia of aging: The role of chronic inflammation and cancer","volume":"45","author":"Ferrucci","year":"2008","journal-title":"Semin. Hematol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4103\/0970-2113.152626","article-title":"Anemia in Chronic obstructive pulmonary disease: Prevalence, pathogenesis, and potential impact","volume":"32","author":"Sarkar","year":"2015","journal-title":"Lung India"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.lungcan.2015.08.017","article-title":"The relationship between COPD and lung cancer","volume":"90","author":"Durham","year":"2015","journal-title":"Lung Cancer"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.lungcan.2016.07.016","article-title":"Chemoradiotherapy versus radiotherapy alone in elderly patients with stage III non-small cell lung cancer: A systematic review and meta-analysis","volume":"99","author":"Dawe","year":"2016","journal-title":"Lung Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/annonc\/mdu268","article-title":"A review of the management of elderly patients with non-small-cell lung cancer","volume":"26","author":"Blanco","year":"2015","journal-title":"Ann. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.1200\/JCO.2007.12.5435","article-title":"Lung cancer in elderly patients: An analysis of the surveillance, epidemiology, and end results database","volume":"25","author":"Owonikoko","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"May, L., Shows, K., Nana-Sinkam, P., Li, H., and Landry, J.W. (2023). Sex Differences in Lung Cancer. Cancers, 15.","DOI":"10.3390\/cancers15123111"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jtho.2017.11.135","article-title":"The Addition of Chemotherapy to Radiation Therapy Improves Survival in Elderly Patients with Stage III Non-Small Cell Lung Cancer","volume":"13","author":"Miller","year":"2018","journal-title":"J. Thorac. Oncol."},{"key":"ref_47","first-page":"647","article-title":"Initial Cancer Treatment in Certified Versus Non-Certified Hospitals","volume":"120","author":"Schmitt","year":"2023","journal-title":"Dtsch. Arztebl. Int."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"11679","DOI":"10.1007\/s00432-023-05025-1","article-title":"Guideline adherence of tumor board recommendations in lung cancer and transfer into clinical practice","volume":"149","author":"Walter","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/2\/327\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:44:57Z","timestamp":1760103897000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/2\/327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,11]]},"references-count":48,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["cancers16020327"],"URL":"https:\/\/doi.org\/10.3390\/cancers16020327","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,11]]}}}